Shop
-
Rybrevant (Amivantamab) – NSCLC | HongKong DengYue Medicine
-
Gazyva (Obinutuzumab) – Follicular Lymphoma | HongKong DengYue Medicine
-
ORPATHYS (Savolitinib Tablets) – NSCLC | HongKong DengYue Medicine
-
Aidaro (Ebdarokimab) – Psoriasis | HongKong DengYue Medicine
-
Fumaining (Luvometinib) – NF1-PN | HongKong DengYue Medicine
-
Zepsun (Donafenib Tosilate) – HCC | HongKong DengYue Medicine
-
Partruvix (Pamiparib) – gBRCA | HongKong DengYue Medicine
-
Nubeqa (Darolutamide) – Prostate Cancer | HongKong DengYue Medicine
-
Taiai (Telitacicept) – SLE | HongKong DengYue Medicine
-
Oncorine (Recombinant Human Adenovirus 5 Injection) – Nasopharyngeal Carcinoma | HongKong DengYue Medicine
-
Simponi (Golimumab) – IMIDs | HongKong DengYue Medicine
-
ADCETRIS (Brentuximab Vedotin) – CD30-positive lymphoma | HongKong DengYue Medicine
-
Esbriet (Pirfenidone) – IPF | HongKong DengYue Medicine
-
Hainaan (Deutenzalutamide) – Prostate Cancer | HongKong DengYue Medicine
-
Tazverik (Tazemetostat) – Sarcoma | HongKong DengYue Medicine
-
Stelara (Ustekinumab) – Immunomodulator | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights